2016 update of the Portuguese recommendations for the use of biological therapies in children and adolescents with Juvenile Idiopathic Arthritis

Maria José Santos; M. Conde; A. F. Mourão; F. O. Ramos; M. Cabral; I. Brito; M. P. Ramos; R. C. Marques; S. M. Gomes; M. Guedes; M. J. Gonçalves; P. Estanqueiro; C. Zilhão; M. Rodrigues; C. Henriques; M. Salgado; H. Canhão; J. E. Fonseca; J. M. Gomes

2016 update of the Portuguese recommendations for the use of biological therapies in children and adolescents with Juvenile Idiopathic Arthritis

Maria José Santos, M. Conde, A. F. Mourão, F. O. Ramos, M. Cabral, I. Brito, M. P. Ramos, R. C. Marques, S. M. Gomes, M. Guedes, M. J. Gonçalves, P. Estanqueiro, C. Zilhão, M. Rodrigues, C. Henriques, M. Salgado, H. Canhão, J. E. Fonseca, J. M. Gomes

Research output: Contribution to journal › Article › peer-review

6 Citations (Scopus)

Abstract

Objective: To provide evidence-based guidance for the rational and safe prescription of biological therapies in children and adolescents with juvenile idiopathic arthritis (JIAs), considering the latest available evidence and the new licensed biologics. Methods: Rheumatologists and Pediatricians with expertise in Pediatric Rheumatology updated the recommendations endorsed by the Portuguese Society of Rheumatology and the Portuguese Society of Pediatrics based on published evidence and expert opinion. The level of agreement with final propositions was voted using an online survey. Results: In total, 20 recommendations to guide the use of biological therapy in children and adolescents with JIAs are issued, comprising 4 general principles and 16 specific recommendations. A consensus was achieved regarding the eligibility and response criteria, maintenance of biological therapy, and procedures in case of non-res - ponse, for each JIA category. Specific recommendations concerning safety procedures were also updated. Conclusions: These recommendations take into account the specificities of each JIA category and are in-tended to continuously improve the management of JIA patients.

Original language	English
Pages (from-to)	194-212
Number of pages	19
Journal	Acta Reumatologica Portuguesa
Volume	2016
Issue number	3
Publication status	Published - 2016

Keywords

Biological agents
Juvenile idiopathic arthritis
Recommendations

Cite this

Santos, M. J., Conde, M., Mourão, A. F., Ramos, F. O., Cabral, M., Brito, I., Ramos, M. P., Marques, R. C., Gomes, S. M., Guedes, M., Gonçalves, M. J., Estanqueiro, P., Zilhão, C., Rodrigues, M., Henriques, C., Salgado, M., Canhão, H., Fonseca, J. E., & Gomes, J. M. (2016). 2016 update of the Portuguese recommendations for the use of biological therapies in children and adolescents with Juvenile Idiopathic Arthritis. Acta Reumatologica Portuguesa, 2016(3), 194-212.

@article{c4bbe743ae2d48ffa341aaa6ae4ff380,

title = "2016 update of the Portuguese recommendations for the use of biological therapies in children and adolescents with Juvenile Idiopathic Arthritis",

abstract = "Objective: To provide evidence-based guidance for the rational and safe prescription of biological therapies in children and adolescents with juvenile idiopathic arthritis (JIAs), considering the latest available evidence and the new licensed biologics. Methods: Rheumatologists and Pediatricians with expertise in Pediatric Rheumatology updated the recommendations endorsed by the Portuguese Society of Rheumatology and the Portuguese Society of Pediatrics based on published evidence and expert opinion. The level of agreement with final propositions was voted using an online survey. Results: In total, 20 recommendations to guide the use of biological therapy in children and adolescents with JIAs are issued, comprising 4 general principles and 16 specific recommendations. A consensus was achieved regarding the eligibility and response criteria, maintenance of biological therapy, and procedures in case of non-res - ponse, for each JIA category. Specific recommendations concerning safety procedures were also updated. Conclusions: These recommendations take into account the specificities of each JIA category and are in-tended to continuously improve the management of JIA patients.",

keywords = "Biological agents, Juvenile idiopathic arthritis, Recommendations",

author = "Santos, {Maria Jos{\'e}} and M. Conde and Mour{\~a}o, {A. F.} and Ramos, {F. O.} and M. Cabral and I. Brito and Ramos, {M. P.} and Marques, {R. C.} and Gomes, {S. M.} and M. Guedes and Gon{\c c}alves, {M. J.} and P. Estanqueiro and C. Zilh{\~a}o and M. Rodrigues and C. Henriques and M. Salgado and H. Canh{\~a}o and Fonseca, {J. E.} and Gomes, {J. M.}",

year = "2016",

language = "English",

volume = "2016",

pages = "194--212",

journal = "Acta Reumatologica Portuguesa",

issn = "0303-464X",

publisher = "Sociedade Portuguesa de Reumatologia",

number = "3",

}

Santos, MJ, Conde, M, Mourão, AF, Ramos, FO, Cabral, M, Brito, I, Ramos, MP, Marques, RC, Gomes, SM, Guedes, M, Gonçalves, MJ, Estanqueiro, P, Zilhão, C, Rodrigues, M, Henriques, C, Salgado, M, Canhão, H, Fonseca, JE & Gomes, JM 2016, '2016 update of the Portuguese recommendations for the use of biological therapies in children and adolescents with Juvenile Idiopathic Arthritis', Acta Reumatologica Portuguesa, vol. 2016, no. 3, pp. 194-212.

TY - JOUR

T1 - 2016 update of the Portuguese recommendations for the use of biological therapies in children and adolescents with Juvenile Idiopathic Arthritis

AU - Santos, Maria José

AU - Conde, M.

AU - Mourão, A. F.

AU - Ramos, F. O.

AU - Cabral, M.

AU - Brito, I.

AU - Ramos, M. P.

AU - Marques, R. C.

AU - Gomes, S. M.

AU - Guedes, M.

AU - Gonçalves, M. J.

AU - Estanqueiro, P.

AU - Zilhão, C.

AU - Rodrigues, M.

AU - Henriques, C.

AU - Salgado, M.

AU - Canhão, H.

AU - Fonseca, J. E.

AU - Gomes, J. M.

PY - 2016

Y1 - 2016

N2 - Objective: To provide evidence-based guidance for the rational and safe prescription of biological therapies in children and adolescents with juvenile idiopathic arthritis (JIAs), considering the latest available evidence and the new licensed biologics. Methods: Rheumatologists and Pediatricians with expertise in Pediatric Rheumatology updated the recommendations endorsed by the Portuguese Society of Rheumatology and the Portuguese Society of Pediatrics based on published evidence and expert opinion. The level of agreement with final propositions was voted using an online survey. Results: In total, 20 recommendations to guide the use of biological therapy in children and adolescents with JIAs are issued, comprising 4 general principles and 16 specific recommendations. A consensus was achieved regarding the eligibility and response criteria, maintenance of biological therapy, and procedures in case of non-res - ponse, for each JIA category. Specific recommendations concerning safety procedures were also updated. Conclusions: These recommendations take into account the specificities of each JIA category and are in-tended to continuously improve the management of JIA patients.

AB - Objective: To provide evidence-based guidance for the rational and safe prescription of biological therapies in children and adolescents with juvenile idiopathic arthritis (JIAs), considering the latest available evidence and the new licensed biologics. Methods: Rheumatologists and Pediatricians with expertise in Pediatric Rheumatology updated the recommendations endorsed by the Portuguese Society of Rheumatology and the Portuguese Society of Pediatrics based on published evidence and expert opinion. The level of agreement with final propositions was voted using an online survey. Results: In total, 20 recommendations to guide the use of biological therapy in children and adolescents with JIAs are issued, comprising 4 general principles and 16 specific recommendations. A consensus was achieved regarding the eligibility and response criteria, maintenance of biological therapy, and procedures in case of non-res - ponse, for each JIA category. Specific recommendations concerning safety procedures were also updated. Conclusions: These recommendations take into account the specificities of each JIA category and are in-tended to continuously improve the management of JIA patients.

KW - Biological agents

KW - Juvenile idiopathic arthritis

KW - Recommendations

UR - http://www.scopus.com/inward/record.url?scp=84994175598&partnerID=8YFLogxK

M3 - Article

C2 - 27770754

AN - SCOPUS:84994175598

SN - 0303-464X

VL - 2016

SP - 194

EP - 212

JO - Acta Reumatologica Portuguesa

JF - Acta Reumatologica Portuguesa

IS - 3

ER -

2016 update of the Portuguese recommendations for the use of biological therapies in children and adolescents with Juvenile Idiopathic Arthritis

Abstract

Keywords

Other files and links

Fingerprint

Cite this